Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
You must be enrolled in Part D to participate
Its biopharma analysts believe obesity treatment is on the cusp of moving into primary care management, and noting the rise of semaglutide drugs like Ozempic and Wegovy for weight loss in the last two years, they estimate obesity revenues to exceed $50B in the US and $75B globally by 2030
Here's what the clinical data says about it
GLP-1 medications can reduce visceral fat, which may improve testosterone levels in some men
10.1016/S0006-2952(03)00504-5 52
Tirzepatide is a once-weekly injectable medication, FDA-approved under the brand name Mounjaro to treat type 2 diabetes and FDA-approved under the brand name Zepbound for weight loss
US$ 28.73
US$ 28.11
US$ 22.83
US$ 20.52
US$ 20.94
US$ 25.71
